Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · IEX Real-Time Price · USD
5.11
+0.07 (1.39%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Abeona Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Abeona Therapeutics stock have an average target of 19, with a low estimate of 15 and a high estimate of 21. The average target predicts an increase of 271.82% from the current stock price of 5.11.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ABEO stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +193.54% | Jul 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +193.54% | Jul 3, 2024 |
| Stifel | Stifel | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +310.96% | May 30, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $28 → $21 | Buy | Maintains | $28 → $21 | +310.96% | May 16, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $36 | Buy | Reiterates | $36 | +604.50% | Apr 23, 2024 |
Financial Forecast
Revenue This Year
306.00K
from 3.50M
Decreased by -91.26%
Revenue Next Year
16.87M
from 306.00K
Increased by 5,414.38%
EPS This Year
-1.93
from -2.53
EPS Next Year
-1.47
from -1.93
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.6M | 25.8M | 148.9M | 276.8M | 422.2M |
| Avg | 306,000 | 16.9M | 90.4M | 205.3M | 303.7M |
| Low | n/a | 9.8M | 37.2M | 106.3M | 148.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -55.0% | 8,341.2% | 782.7% | 206.3% | 105.7% |
| Avg | -91.3% | 5,414.4% | 435.5% | 127.2% | 48.0% |
| Low | - | 3,102.6% | 120.7% | 17.7% | -27.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.43 | -1.17 | 0.20 | 3.26 | 5.95 |
| Avg | -1.93 | -1.47 | -0.43 | 3.16 | 5.78 |
| Low | -2.09 | -1.70 | -0.84 | 3.04 | 5.56 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 88.3% |
| Avg | - | - | - | - | 82.9% |
| Low | - | - | - | - | 75.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.